| Erratum in the breakpoint table v 11.0 |
Erratum in the Staphylococcus spp tab (fluroquinolone section): Footnote C should read: Isolates categorised as susceptible to norfloxacin can be reported susceptible (S) to moxifloxacin and "susceptible increased exposure" (I) to ciprofloxacin and levofloxacin. Isolates non-wild type to norfloxacin should be tested for susceptibility to individual agents. |
 |
|
2021/03/11 |
| New and updated Rational Documents published |
Ten new or updated Rationale Documents were published (and stamped in the list with) 2021-02-08. |
|
|
2021/02/08 |
| Online seminars - new subjects |
EUCAST is looking for input from users on which titles for online seminars to concentrate on during 2021. |
|
|
2021/02/03 |
| RAST breakpoint tables updated |
|
|
|
2020/12/30 |
| QC tables updated |
|
|
|
2020/12/30 |
| Updated EUCAST disk diffusion manuals |
|
|
|
2020/12/30 |
| Updated broth microdilution reading guideline |
|
|
|
2020/12/30 |
| Updated breakpoint tables 2021 |
|
|
|
2020/12/30 |
| Comments and responses to consultation of breakpoint table v 11.0 |
The 2021 version 11.0 breakpoint table was open for comments 4 December - 18 December, 2020. Comments and EUCAST responses now published. |
|
|
2020/12/19 |
| EUCAST AFST method on BMD of dermatophytes available |
https://authors.elsevier.com/a/1cGKm,RGPgHunp |
|
|
2020/12/19 |
| Cefiderocol broth microdilution MIC testing |
Cefiderocol broth microdilution MIC determination - guidance. |
|
|
2020/12/17 |
| Publications from the EUCAST Subcommittee on antimycobacterial susceptibility testing online |
|
|
|
2020/12/17 |
| Comments and EUCAST responses to several consultations |
There were comments (and now EUCAST response) to consultations on fosfomycin, piperacillin-tazobactam, Achromobacter, Bacillus spp breakpoints |
|
|
2020/12/15 |
| Two laboratories added to the AFST network of laboratories |
|
|
|
2020/12/09 |
| Breakpoint table v 11.0 posted for consultation 4 Dec - 18 Dec, 2020. |
This table, with relevant changes following consultation, will become the 2021 breakpoint table for bacteria from EUCAST (1 January, 2021).
Please address comments to erika.matuschek[at]eucast.org. |
|
|
2020/12/04 |
| EUCAST zoomseminars |
Several EUCAST online seminars are offered on the homepage of EUCAST |
|
|
2020/11/28 |
| EUCAST Maps updated with two new countries |
|
|
|
2020/11/25 |
| New software for the display of MIC andzone diameter distributions |
The EUCAST MIC and zone diameter distribution software, originally created in 2003, for displaying distributions of MIC-values (generated with methods calibrated to broth microdilution or agar dilution) and inhibition zone diameters (generated with EUCAST disk diffusion methodology) has been re-programmed and re-launched 24 November, 2020. Each graph is shown in two versions where one is constructed by adding all approved distributions and the other by adding weighted distributions. The later is generated through converting numbers to per cent before adding individual distributions. This prevents large distributions from dominating or even "obliterating" smaller distributions and allows all distributions equal weight. During 2021 distributions are curated in accordance with EUCAST SOP10.1 and all values gradually reviewed. |
|
|
2020/11/24 |
| EUCAST maps updated |
The maps showing EUCAST uptake were updated. |
|
|
2020/11/05 |
| Fosfomycin breakpoint revision |
Consultation on changing breakpoints |
|
|
2020/11/02 |
| Flurorquinolone breakpoint adjustments to Campylobacter, Corynebacteria and Bacillus - consultation 12 - 31 October, 2020. |
|
|
|
2020/10/12 |
| Achromobacter xylosoxidans - method and breakpoints proposed. |
|
|
|
2020/10/05 |
| EUCAST referenc e for BMD of M.tuberculosis complex |
|
|
|
2020/09/04 |
| General consultation on revised meningitis breakpoints |
EUCAST has reviewed and in some instances proposed a revision of breakpoints used for bacteria causing meningitis. The consultation is open until 16 October, 2020. |
|
|
2020/08/31 |
| B. pseudomallei MIC and zone diameter correlates published |
Methods, breakpoints and calibration of MIC vs. zone diameters published. |
|
|
2020/08/29 |
| Proposed breakpoints for Bacillus spp. |
EUCAST breakpoints for Bacillus spp (except B. anthracis) - consultation 25 August - 25 September, 2020. |
|
|
2020/08/25 |
| Clinical trial of blood culture RAST in 55 laboratories published |
|
|
|
2020/08/14 |
| SOP 8 updated |
|
|
|
2020/07/30 |
| SOP 3,4, 7 and 8 updated |
|
|
|
2020/07/30 |
| General consultation on proposed changes to piperacillin-tazobactam breakpoints |
|
|
|
2020/07/17 |
| Consultation on proposed bacterial meningitis breakpoints |
|
|
|
2020/07/17 |
| Oral cephalosporins and Enterobacterales breakpoints - updated guidance document. |
|
|
|
2020/07/14 |
| SOP 9.2 and SOP 11.0 published |
EUCAST SOP 9.2 revised and SOP 11.0 published. |
|
|
2020/07/13 |
| Ceftolozane-tazobactam zone diameter breakpoints for H. influenzae available |
|
|
|
2020/06/16 |
| S.pneumoniae - panel of 10 strains with reference MICs available |
EUCAST and CCUG in collaboration have made a panel of 10 strains with reference MICs available. Strains were selected on the basis of the varying susceptibility to betalactam agents. |
|
|
2020/06/04 |
| Ceftolozane-tazobactam rationale document published |
|
|
|
2020/05/15 |
| EUCAST 2019 - 20. The chairman´s report. |
The EUCAST General Committee meeting at ECCMID 2020 was cancelled due to COVID19.
The EUCAST Steering Committee and subcommittees have, under the heading of the traditional Chairman´s report, summarised the last 12 months of activity. |
|
|
2020/05/04 |
| Cefiderocol breakpoints and AST methods |
Addendum to the EUCAST breakpoint table v 10.0: Cefiderocol breakpoints and AST methods (30 April, 2020) |
|
|
2020/04/30 |
| Rationale documents for amikacin, gentamicin and tobramycin updated |
|
|
|
2020/04/30 |
| EUCAST position paper on daptomycin in Enterococcal blood stream infections and endocarditis. |
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper Clinical Microbiology and Infection, 2020. |
|
|
2020/04/28 |
| Warnings against gradient tests for piperacillin-tazobactam removed |
|
|
|
2020/04/24 |
| Aminoglycoside guidance document updated |
The guidance document on aminoglycoside dosing, first published 21 Jan, 2020, was updated 24 April, 2020. |
|
|
2020/04/24 |
| Temocillin breakpoints published |
|
|
|
2020/04/21 |
| Temocillin rationale document published |
|
|
|
2020/04/21 |
| RAST breakpoint table v 2.1 (as a substitute for 2.0) published |
Because of an error in the tab E. faecalis, a corrected version 2.1 is published. The only change is in the E.F faecalis tab. |
|
|
2020/04/20 |
| Aminoglycoside MIC distributions and ECOFFs reviewed in accordance with SOP 10.1 |
|
|
|
2020/04/12 |
| EUCAST instruction videos with Romanian subtitles |
|
|
|
2020/04/07 |
| Daptomycin and temocillin MIC data and ECOFFs reviewed |
|
|
|
2020/04/06 |
| EUCAST advice on intrinsic resistance and unusual phenotypes updated. |
|
|
|
2020/03/03 |
| EUCAST broth microdilution reading guide updated |
EUCAST broth microdilution reading guide updated to version 2.0 with specific reading instructions for Gram-negative organisms with tigecycline and eravacycline added. |
|
|
2020/03/02 |
